Literature DB >> 30894370

Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.

Amit K Srivastava1, Ananya Banerjee1,2, Tiantian Cui1, Chunhua Han1, Shurui Cai1, Lu Liu1,3, Dayong Wu1, Ri Cui4, Zaibo Li5, Xiaoli Zhang6, Guozhen Xie1, Karuppaiyah Selvendiran7, Srinivas Patnaik2, Adam R Karpf8, Jinsong Liu9, David E Cohn7, Qi-En Wang10,11.   

Abstract

Cancer stem cells (CSC) play a central role in cancer metastasis and development of drug resistance. miRNA are important in regulating CSC properties and are considered potential therapeutic targets. Here we report that miR-328-3p (miR-328) is significantly upregulated in ovarian CSC. High expression of miR-328 maintained CSC properties by directly targeting DNA damage binding protein 2, which has been shown previously to inhibit ovarian CSC. Reduced activity of ERK signaling in ovarian CSC, mainly due to a low level of reactive oxygen species, contributed to the enhanced expression of miR-328 and maintenance of CSC. Inhibition of miR-328 in mouse orthotopic ovarian xenografts impeded tumor growth and prevented tumor metastasis. In summary, our findings provide a novel mechanism underlying maintenance of the CSC population in ovarian cancer and suggest that targeted inhibition of miR-328 could be exploited for the eradication of CSC and aversion of tumor metastasis in ovarian cancer. SIGNIFICANCE: These findings present inhibition of miR-328 as a novel strategy for efficient elimination of CSC to prevent tumor metastasis and recurrence in patients with epithelial ovarian cancer. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 30894370      PMCID: PMC6777340          DOI: 10.1158/0008-5472.CAN-18-3668

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

1.  Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells.

Authors:  Amit Kumar Srivastava; Chunhua Han; Ran Zhao; Tiantian Cui; Yuntao Dai; Charlene Mao; Weiqiang Zhao; Xiaoli Zhang; Jianhua Yu; Qi-En Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

2.  Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

Authors:  Ines A Silva; Shoumei Bai; Karen McLean; Kun Yang; Kent Griffith; Dafydd Thomas; Christophe Ginestier; Carolyn Johnston; Angela Kueck; R Kevin Reynolds; Max S Wicha; Ronald J Buckanovich
Journal:  Cancer Res       Date:  2011-04-15       Impact factor: 12.701

3.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

Authors:  Yifang Hu; Gordon K Smyth
Journal:  J Immunol Methods       Date:  2009-06-28       Impact factor: 2.303

4.  Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells.

Authors:  T Burdon; C Stracey; I Chambers; J Nichols; A Smith
Journal:  Dev Biol       Date:  1999-06-01       Impact factor: 3.582

Review 5.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

Review 6.  Targeting RAS-ERK signalling in cancer: promises and challenges.

Authors:  Ahmed A Samatar; Poulikos I Poulikakos
Journal:  Nat Rev Drug Discov       Date:  2014-12       Impact factor: 84.694

7.  Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.

Authors:  Bassant M Barakat; Qi-En Wang; Chunhua Han; Keisha Milum; De-Tao Yin; Qun Zhao; Gulzar Wani; El-Shaimaa A Arafa; Mohamed A El-Mahdy; Altaf A Wani
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

8.  DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

Authors:  Nilotpal Roy; Prashant V Bommi; Uppoor G Bhat; Shaumick Bhattacharjee; Indira Elangovan; Jing Li; Krushna C Patra; Dragana Kopanja; Adam Blunier; Richard Benya; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

9.  DDB2: a novel regulator of NF-κB and breast tumor invasion.

Authors:  Marie Ennen; Rémi Klotz; Nadège Touche; Sophie Pinel; Claire Barbieux; Vanessa Besancenot; Emilie Brunner; Denise Thiebaut; Alain C Jung; Sonia Ledrappier; Lionel Domenjoud; Joseph Abecassis; François Plénat; Stéphanie Grandemange; Philippe Becuwe
Journal:  Cancer Res       Date:  2013-06-17       Impact factor: 12.701

10.  DDB2 decides cell fate following DNA damage.

Authors:  Tanya Stoyanova; Nilotpal Roy; Dragana Kopanja; Srilata Bagchi; Pradip Raychaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-16       Impact factor: 11.205

View more
  26 in total

1.  Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer.

Authors:  Caglar Berkel; Ercan Cacan
Journal:  Hum Cell       Date:  2021-02-12       Impact factor: 4.174

2.  MZF1 Transcriptionally Activated MicroRNA-328-3p Suppresses the Malignancy of Stomach Adenocarcinoma via Inhibiting CD44.

Authors:  Zining Qi; Jing Wang; Yaoping Li; Yanzhao Xu
Journal:  J Immunol Res       Date:  2022-05-28       Impact factor: 4.493

Review 3.  Circular RNAs: new biomarkers of chemoresistance in cancer.

Authors:  Jiaqi Wang; Yi Zhang; Lianyu Liu; Ting Yang; Jun Song
Journal:  Cancer Biol Med       Date:  2021-03-19       Impact factor: 4.248

4.  CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines.

Authors:  Alessio Biagioni; Anastasia Chillà; Mario Del Rosso; Gabriella Fibbi; Francesca Scavone; Elena Andreucci; Silvia Peppicelli; Francesca Bianchini; Lido Calorini; Anna Li Santi; Pia Ragno; Francesca Margheri; Anna Laurenzana
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

5.  miR-328-3p overexpression attenuates the malignant proliferation and invasion of liver cancer via targeting Endoplasmic Reticulum Metallo Protease 1 to inhibit AKT phosphorylation.

Authors:  Hua Lu; Jiali Hu; Jianping Li; Weifeng Lu; Xiaofan Deng; Xu Wang
Journal:  Ann Transl Med       Date:  2020-06

Review 6.  Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.

Authors:  Abdul Q Khan; Eiman I Ahmed; Noor R Elareer; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cells       Date:  2019-08-05       Impact factor: 6.600

7.  MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3.

Authors:  Jun Wang; Xiaojuan Li; Zhaoming Xiao; Yu Wang; Yuefu Han; Jun Li; Weian Zhu; Qu Leng; Yuehui Wen; Xinqiao Wen
Journal:  FEBS Open Bio       Date:  2019-08-22       Impact factor: 2.693

8.  Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer.

Authors:  Nur Selvi Gunel; Nihal Birden; Cansu Caliskan Kurt; Bakiye Goker Bagca; Behrouz Shademan; Fatma Sogutlu; Neslihan Pinar Ozates; Cigir Biray Avci
Journal:  Mol Biol Rep       Date:  2021-08-10       Impact factor: 2.316

9.  In silico model for miRNA-mediated regulatory network in cancer.

Authors:  Khandakar Tanvir Ahmed; Jiao Sun; William Chen; Irene Martinez; Sze Cheng; Wencai Zhang; Jeongsik Yong; Wei Zhang
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 13.994

10.  MicroRNA-214-3p targets the PLAGL2-MYH9 axis to suppress tumor proliferation and metastasis in human colorectal cancer.

Authors:  Zili Zhou; Liang Wu; Zhengyi Liu; Xudan Zhang; Shengbo Han; Ning Zhao; Haijun Bao; Wenzheng Yuan; Jinhuang Chen; Jintong Ji; Xiaogang Shu
Journal:  Aging (Albany NY)       Date:  2020-05-15       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.